Dynacare Laboratories, Toronto, Ontario, Canada.
University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada.
J Crohns Colitis. 2023 May 3;17(5):767-776. doi: 10.1093/ecco-jcc/jjac178.
This study examines colonic histological features in ulcerative colitis [UC] in endoscopic remission to determine which cell types and biopsy sites best predict a patient's likelihood of remaining in remission.
This is a retrospective chart, endoscopy and histology review of 166 patients with UC in endoscopic remission followed in a single inflammatory bowel disease practice over a median of 6 years [range, 2-11 years]. Clinical remission was based on global physician assessment and colonoscopy reports, and clinical relapse on chart review. Histological features of previous injury and also number and location of plasma cells and eosinophils were assessed. We evaluated all of these features semi-quantitatively using a standard set of illustrations for the grade to maintain consistency. Multiple logistic regression and survival analyses were used to identify features associated with relapse.
Clinical relapse occurred in 44 patients. Ulceration, especially in the left colon, was highly predictive of relapse. In the absence of acute inflammation of ulceration, the variables most predictive of relapse were increased plasma cells in the basal 20% of the lamina propria, and eosinophils in the left colon. The variable most predictive of persistent remission was the presence of intra-epithelial eosinophils whether in the surface epithelium or within crypts, especially in the right colon. Lamina propria eosinophils [grade > 2] throughout the colon predicted relapse.
In the absence of neutrophils or ulceration, left-sided plasmacytosis in the basal 20% of the lamina propria and increased lamina propria eosinophils provide the best indicators of relapse in UC in clinical and endoscopic remission.
本研究通过检查处于内镜缓解期的溃疡性结肠炎[UC]的结肠组织学特征,以确定哪些细胞类型和活检部位最能预测患者保持缓解的可能性。
这是一项对在单家炎症性肠病诊所中接受内镜缓解期 UC 随访的 166 例患者进行的回顾性图表、内镜和组织学审查,中位随访时间为 6 年[范围,2-11 年]。临床缓解基于全球医生评估和结肠镜报告,临床复发基于图表审查。评估了先前损伤的组织学特征以及浆细胞和嗜酸性粒细胞的数量和位置。我们使用一套标准插图对半定量评估所有这些特征,以保持一致性。使用多元逻辑回归和生存分析来确定与复发相关的特征。
44 例患者出现临床复发。溃疡,特别是左结肠的溃疡,高度提示复发。在没有溃疡急性炎症的情况下,最能预测复发的变量是固有层基底部 20%的浆细胞增多,以及左结肠的嗜酸性粒细胞增多。最能预测持续缓解的变量是上皮内嗜酸性粒细胞的存在,无论是在上皮表面还是在隐窝内,尤其是在右结肠。整个结肠固有层嗜酸性粒细胞[等级>2]提示复发。
在没有中性粒细胞或溃疡的情况下,固有层基底部 20%的浆细胞增多和固有层嗜酸性粒细胞增多是溃疡性结肠炎在临床和内镜缓解期复发的最佳指标。